China’s animal vaccine industry has been growing fast. The market maintained an average annual growth rate of 13.6 per cent in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0 per cent YoY, according to a new report published by Research and Markets.

Climate change and increased urbanisation are posing new challenges to animal disease prevention and control.

GLOBAL ANIMAL HEALTH company Merial and the Australian company Imugene have signed a comprehensive agreement allowing Merial to obtain exclusive rights to Imugene vector technology.